407 related articles for article (PubMed ID: 17693049)
21. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
22. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
[TBL] [Abstract][Full Text] [Related]
23. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
[TBL] [Abstract][Full Text] [Related]
24. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
[TBL] [Abstract][Full Text] [Related]
25. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Muley T; Dienemann H; Ebert W
Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
[TBL] [Abstract][Full Text] [Related]
26. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
27. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
[TBL] [Abstract][Full Text] [Related]
28. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
[TBL] [Abstract][Full Text] [Related]
29. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
[TBL] [Abstract][Full Text] [Related]
30. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining.
Skagias L; Politi E; Karameris A; Sambaziotis D; Archondakis A; Ntinis A; Moreas I; Vasou O; Koutselini H; Patsouris E
Anticancer Res; 2009 Oct; 29(10):4163-7. PubMed ID: 19846967
[TBL] [Abstract][Full Text] [Related]
31. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
[TBL] [Abstract][Full Text] [Related]
33. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
34. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
36. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Chiyo M; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Agamy G; El-Shahhat H; Fujisawa T; Yoshino I
Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
[TBL] [Abstract][Full Text] [Related]
37. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
Keum JS; Kong G; Yang SC; Shin DH; Park SS; Lee JH; Lee JD
Br J Cancer; 1999 Sep; 81(1):127-32. PubMed ID: 10487623
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers.
Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S
Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721
[TBL] [Abstract][Full Text] [Related]
40. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
